Input provided by Florian Grebien

Scientific and social implications of the CRISPR technology

Moderation: Lisa Sigl

When: June 11, 2018, 12.00-14.00
Where: Library of the Department of Science and Technology Studies, University of Vienna, Neues Institutsgebäude, Universitätsstraße 7/6th floor

All are welcome, but please RSVP (sending a message to corinna.wegscheider@univie.ac.at) by June 07, 2018 to ensure that we have enough food and drinks.

Florian Grebien did his PhD jointly supervised by Ernst Müllner of the Medical University Vienna and Hartmut Beug of the Research Institute for Molecular Pathology (IMP) in Vienna. For his post-doctoral research he joined the team of Giulio Superti-Furga at the Research Center for Molecular Medicine (CeMM), Vienna. Since 2014 he leads an independent research team at the LBI-CR. In January 2018, he was appointed Professor and head of the Institute for Medical Biochemistry at the University of Veterinary Medicine Vienna. Dr. Grebien's research is funded by the starting grant "ONCOMECHAML" from the European Research Council (ERC). Florian Grebien’s research focuses on acute myeloid leukemia (AML), a cancer of white blood cells that is characterized by the rapid growth of abnormal myeloid cells that accumulate in the bone marrow and interfere with the production of normal blood cells. The laboratory of Florian Grebien aims to contribute to a better understanding of the molecular mechanisms of leukemia development through the development and use of novel tools for functional evaluation of oncogenic aberrations.

With the CRISPR Forum we wish to continue and deepen the conversation on editing genomes with CRISPR that we have begun with an international symposium in October 2017.

Organized by the University of Vienna’s Department of Ecogenomics and Systems Biology, the Department of Science and Technology Studies, and the Research Platform Responsible Research and Innovation.